OxfordVR gameChange
Oxford VR
NHS-approved automated VR therapy for agoraphobia in psychosis patients
About OxfordVR gameChange
gameChange is an automated VR cognitive therapy program developed by Oxford University, Oxford VR, and multiple NHS Trusts, recommended for use in NHS mental health services for treating severe agoraphobia in patients with psychosis. It represents the first-ever VR treatment approved for NHS mental health services. The program enables largely housebound patients with agoraphobia to safely practice re-entering everyday situations through immersive VR environments. A virtual coach guides patients through CBT-based exposure therapy, eliminating the need for a real therapist during sessions. Clinical trials led by Professor Daniel Freeman showed significant reductions in avoidance and distress, with patients who were most severely affected experiencing the largest benefits, including being able to undertake activities they had previously found unthinkable.
Best For
- • NHS mental health services
- • psychosis treatment teams
- • and clinicians treating severe agoraphobia in patients with psychotic disorders
Not Ideal For
- • US-based practices (currently UK NHS only)
- • or treating agoraphobia without comorbid psychosis
Pricing
Contact for pricing
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Settings
Related Tools
XRHealth
FDA-registered VR therapeutic platform with Medicare-reimbursed telehealth
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.
Big Health (Sleepio, Daylight)
First FDA-cleared DTx for anxiety (DaylightRx) and insomnia (SleepioRx) with Medicare coverage.
Blueprint
Free EHR with AI assistant and measurement-based care for therapists.